£51.20

Academic Press Molecular Targets in Protein Misfolding and Neurodegenerative Disease: Focus on Tau, Alzheimer's Disease, and Other Tauopathies

Price data last checked 116 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£51 today · usual range £0–£0 · best ever £28

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 615 days • 615 data points (No recent data available)

Historical
Generating forecast...
£75.99 £22.85 £34.44 £46.04 £57.63 £69.23 £80.82 09 June 2024 09 November 2024 12 April 2025 12 September 2025 13 February 2026

Price Distribution

Price distribution over 615 days • 5 price ranges

Days at Price
Current Price
18 days 19 days 137 days · current 106 days 335 days 0 84 168 251 335 £28-37 £37-47 £47-57 £57-66 £66-76 Days at Price

Price Analysis

Most common range: £66-76 (335 days, 54.5%)

Price range: £28 - £76

Price levels: 5 price ranges over 615 days

Description

Aimed at "drug discoverers" - i.e. any scientist who is interested in neurodegenerative diseases in general, and in finding disease-modifying treatments in particular - the first edition of Molecular Targets in Protein Misfolding and Neurodegenerative Disease will contain both a detailed, discipline-specific coverage (paragraphs on medicinal chemistry, on clinical and preclinical characterization of compounds in development, on target identification and validation, on genetic factors influencing a pathology, etc.) and a drug discovery-oriented, overall evaluation of each target (validation, druggability, existing leads, etc.). Together these will satisfy the needs of various audiences, including in vitro biologists, pharmacologists, medicinal chemists, etc. * Written to provide a comprehensive coverage of disease-modifying mechanisms and compounds against neurodegenerative diseases* Provides a "drug discovery application oriented perspective, evaluating targets and candidates for their overall therapeutic potential* Provides discipline-specific chapters (medicinal chemistry, target validation, preclinical and clinical development* Provides an overview on a number of molecular mechanisms (e.g. phosphorylation, chaperon refolding, ubiquitination, autophagy, microtubule transportation, protease cleavage, etc.) with relevance for any disease area* Contains a more thorough description of the therapeutic relevance of ~10 specific molecular targets

Product Specifications

Format
hardcover
Domain
Amazon UK
Publication Date
17 October 2014
Listed Since
02 May 2014

Barcode

No barcode data available

Similar Products You Might Like

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (Enzyme Inhibitors)
97% match

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (Enzyme Inhibitors)

CRC Press

£60.82 24 Feb 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
96% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Academic Press

£52.49 21 Feb 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
96% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Academic Press

£90.48 23 Feb 2026
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (International Society of Neuropathology Series)
96% match

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (International Society of Neuropathology Series)

Wiley-Blackwell

£137.96 12 Jan 2026
Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)
96% match

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)

CRC Press

£192.44 12 Jan 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
96% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Mar 2026
Fundamentals of Neurodegeneration and Protein Misfolding Disorders (Biological and Medical Physics, Biomedical Engineering)
96% match

Fundamentals of Neurodegeneration and Protein Misfolding Disorders (Biological and Medical Physics, Biomedical Engineering)

Springer

£80.09 08 Mar 2026
Fundamentals of Neurodegeneration and Protein Misfolding Disorders (Biological and Medical Physics, Biomedical Engineering)
96% match

Fundamentals of Neurodegeneration and Protein Misfolding Disorders (Biological and Medical Physics, Biomedical Engineering)

Springer

£78.71 09 Jan 2026
Neurodegenerative Diseases: Unifying Principles
96% match

Neurodegenerative Diseases: Unifying Principles

Oxford University Press

£132.45 09 Apr 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
96% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.24 09 Mar 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
96% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£143.46 23 Jan 2026
Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)
96% match

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Springer

£201.98 12 Jan 2026
Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
96% match

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£81.52 28 Feb 2026
Protein Quality Control in Neurodegenerative Diseases (Research and Perspectives in Alzheimer's Disease)
96% match

Protein Quality Control in Neurodegenerative Diseases (Research and Perspectives in Alzheimer's Disease)

Springer

£107.43 17 Mar 2026
Computational and Experimental Studies in Alzheimer's Disease
96% match

Computational and Experimental Studies in Alzheimer's Disease

£107.98 20 Jan 2026
Protein Quality Control in Neurodegenerative Diseases: 0 (Research and Perspectives in Alzheimer's Disease)
96% match

Protein Quality Control in Neurodegenerative Diseases: 0 (Research and Perspectives in Alzheimer's Disease)

Springer

£67.80 15 Apr 2026
Quality Control of Cellular Protein in Neurodegenerative Disorders (Advances in Medical Diagnosis, Treatment, and Care)
96% match

Quality Control of Cellular Protein in Neurodegenerative Disorders (Advances in Medical Diagnosis, Treatment, and Care)

Medical Information Science Reference

£265.87 22 Jan 2026
Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)
96% match

Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)

Academic Press

£114.49 10 Mar 2026
Human Caspases and Neuronal Apoptosis in Neurodegenerative Diseases
96% match

Human Caspases and Neuronal Apoptosis in Neurodegenerative Diseases

Academic Press

£56.67 09 Apr 2026
Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107
96% match

Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107

Academic Press

£96.25 09 Mar 2026
Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)
96% match

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Springer

£127.23 30 Jan 2026
Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)
95% match

Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)

Academic Press

£79.99 11 Mar 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
95% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£169.22 22 Jan 2026
Neurobiology of Huntington's Disease: Applications to Drug Discovery (Frontiers in Neuroscience)
95% match

Neurobiology of Huntington's Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

CRC Press

£125.00 31 Jan 2026